WHO ICTRP trial

EFFIPEC – Efficacy of heated chemotherapy administered into the abdomen

EUCTR2020-005210-18-SE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2020-005210-18-SE
Public title EFFIPEC – Efficacy of heated chemotherapy administered into the abdomen
Scientific title EFFIPEC – Efficacy of Hyperthermic Intraperitoneal Chemotherapy Single-arm Phase I study, followed by an open-label, randomized, controlled registry-based Phase III trial - EFFIPEC
Primary sponsor Uppsala University
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries Sweden
Conditions Colorectal cancer MedDRA version: 27.0 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases…
Interventions Trade Name: Fluorouracil Accord Product Name: 5-fluorouracil Pharmaceutical Form: Solution for infusion INN or Proposed INN: Fluorouracil CAS Number: 51-21-8 Other descriptive name: FLUOROURACIL Trade Name: Irinotecan Accord Product Name…
Registration date Jan 27, 2021
Target size 230
Secondary IDs EFFIPEC01
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations